Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Predictive Oncology ( (POAI) ) has provided an update.
Predictive Oncology Inc., a company involved in the field of oncology, has announced a corporate name change to Axe Compute Inc., effective December 11, 2025. This change, approved by the Board of Directors, does not require stockholder approval and involves the adoption of amended bylaws. The company’s stock will trade under the new ticker symbol ‘AGPU’ on Nasdaq starting December 12, 2025, with no changes to the CUSIP number or the validity of existing stock certificates.
The most recent analyst rating on (POAI) stock is a Hold with a $5.00 price target. To see the full list of analyst forecasts on Predictive Oncology stock, see the POAI Stock Forecast page.
Spark’s Take on POAI Stock
According to Spark, TipRanks’ AI Analyst, POAI is a Neutral.
The overall stock score is primarily impacted by the company’s poor financial performance and valuation, which are offset slightly by positive corporate events such as regaining Nasdaq compliance and securing substantial private placements. The technical analysis indicates bearish momentum, further weighing down the score.
To see Spark’s full report on POAI stock, click here.
More about Predictive Oncology
Average Trading Volume: 104,804
Technical Sentiment Signal: Sell
Current Market Cap: $18.87M
For a thorough assessment of POAI stock, go to TipRanks’ Stock Analysis page.